113 related articles for article (PubMed ID: 15052775)
1. [Chromatin immunoprecipitation and its preliminary application for gene regulation].
Zhang Y; Cheng XK; Wu NH; Shen YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):52-5. PubMed ID: 15052775
[TBL] [Abstract][Full Text] [Related]
2. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
[TBL] [Abstract][Full Text] [Related]
3. [Identification of two new p53 target genes through implementation of the modified chromatin immunoprecipitation method and inverse PCR].
Burgess R; Luniak V; Noskin L; Giliano N
Mol Biol (Mosk); 2002; 36(6):1035-43. PubMed ID: 12500542
[TBL] [Abstract][Full Text] [Related]
4. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
el-Deiry WS; Tokino T; Waldman T; Oliner JD; Velculescu VE; Burrell M; Hill DE; Healy E; Rees JL; Hamilton SR
Cancer Res; 1995 Jul; 55(13):2910-9. PubMed ID: 7796420
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical upregulation of tumor suppressor protein p53 in serum-stimulated vascular smooth muscle cells: a novel negative-feedback regulatory mechanism.
Mnjoyan ZH; Dutta R; Zhang D; Teng BB; Fujise K
Circulation; 2003 Jul; 108(4):464-71. PubMed ID: 12860918
[TBL] [Abstract][Full Text] [Related]
6. [The role of p53 binding site on the trans binding of p53 to Hsp90 beta gene].
Chen LL; Wu NH; Shen YF; Guan XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):285-8. PubMed ID: 12905636
[TBL] [Abstract][Full Text] [Related]
7. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study of p53 gene promoter binding site of activator protein-1 in A549 cell lines by chromatin immunoprecipitation].
Shen F; Li ZT; Wu YM; Wu WD
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Aug; 26(8):453-6. PubMed ID: 19358752
[TBL] [Abstract][Full Text] [Related]
9. Methods to study p53-repressed promoters.
Dumont P; Della Pietra A; Murphy ME
Methods Mol Biol; 2003; 234():111-20. PubMed ID: 12824528
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
11. AP2alpha alters the transcriptional activity and stability of p53.
Stabach PR; Thiyagarajan MM; Woodfield GW; Weigel RJ
Oncogene; 2006 Apr; 25(15):2148-59. PubMed ID: 16288208
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues.
Fredersdorf S; Milne AW; Hall PA; Lu X
Am J Pathol; 1996 Mar; 148(3):825-35. PubMed ID: 8774137
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53.
Tishler RB; Lamppu DM; Park S; Price BD
Cancer Res; 1995 Dec; 55(24):6021-5. PubMed ID: 8521385
[TBL] [Abstract][Full Text] [Related]
15. BAF53 interacts with p53 and functions in p53-mediated p21-gene transcription.
Wang M; Gu C; Qi T; Tang W; Wang L; Wang S; Zeng X
J Biochem; 2007 Nov; 142(5):613-20. PubMed ID: 17878219
[TBL] [Abstract][Full Text] [Related]
16. c-Abl tyrosine kinase activates p21 transcription via interaction with p53.
Jing Y; Wang M; Tang W; Qi T; Gu C; Hao S; Zeng X
J Biochem; 2007 May; 141(5):621-6. PubMed ID: 17339230
[TBL] [Abstract][Full Text] [Related]
17. In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.
Potratz JC; Mlody B; Berdel WE; Serve H; Müller-Tidow C
Int J Oncol; 2005 Feb; 26(2):493-8. PubMed ID: 15645135
[TBL] [Abstract][Full Text] [Related]
18. Generation of p53 target database via integration of microarray and global p53 DNA-binding site analysis.
Liu S; Mirza A; Wang L
Methods Mol Biol; 2004; 281():33-54. PubMed ID: 15220520
[TBL] [Abstract][Full Text] [Related]
19. Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene.
Giraud S; Hurlstone A; Avril S; Coqueret O
Oncogene; 2004 Sep; 23(44):7391-8. PubMed ID: 15286705
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
